Content Syndication Downloads
Content Syndication Downloads are provided as a complimentary service by PentaVision LLC and its magazines. In submitting the registration form you agree to providing express consent to PentaVision LLC to share this contact information with the organization providing white papers that you download from this site.
An Executive Summary and Tips for Treating This Common Form of HSV
Keys to recovery include early diagnosis and timely antiviral therapy to alleviate symptoms, decrease disease severity, and reduce the risk of any corneal complications that could adversely affect the patient’s eyesight.1,2
Initial treatment for HSV dendritic keratitis typically involves topical antiviral agents. The authors choose ganciclovir gel, FDA-approved in 2009, as their preferred first-line topical medication due to its safety, efficacy, and tolerability profile.3
In a new white paper, Dr. Christopher Rapuano and Dr. Joseph Shovlin discuss their preferred treatment options.